SARS-CoV-2 Neutralizing Antibody-Negative Human Serum Reference: 31567-50 Human serum negative for SARS-CoV-2 neutralizing antibodies
Viral Transport Medium, formula CDC Reference: VTM-1000ML VTM allows the safe transfer of viruses, chlamydiae, and mycoplasma for further research including classical cell culture methods, diagnostic testing, as well as molecular biology methods.
SARS-CoV-2 Neutralizing Antibody-Positive Human Serum Reference: 31568-50 Human serum positive for SARS-CoV-2 neutralizing antibodies
Viral Transport Medium, formula CDC Reference: VTM-500ML VTM allows the safe transfer of viruses, chlamydiae, and mycoplasma for further research including classical cell culture methods, diagnostic testing, as well as molecular biology methods.
SARS-CoV-2 Neutralizing Antibody-Negative Pre-pandemic Human Serum Reference: 31569-50 Pre-pandemic human serum negative for SARS-CoV-2 neutralizing antibodies
Viral Transport Medium, formula CDC, with Phenol Red Reference: VTM-R-1000ML VTM allows the safe transfer of viruses, chlamydiae, and mycoplasma for further research including classical cell culture methods, diagnostic testing, as well as molecular biology methods.
SARS-CoV-2 Spike-ACE2 Interaction Inhibitor Screening Assay Kit Reference: 502050-96solid Cayman’s SARS-CoV-2 Spike-ACE2 Interaction Inhibitor Screening Assay Kit provides a robust and easy-to-use platform for identifying novel inhibitors of the SARS-CoV-2 spike and ACE2 interaction. The assay uses a recombinant rabbit Fc-tagged SARS-CoV-2 spike S1 RBD that binds to a plate precoated with a mouse anti-rabbit antibody. A recombinant His-tagged ACE2 protein binds the spike RBD and the complex is detected with an HRP-conjugated anti-His antibody, which is easily quantified by reading the absorbance at 450 nm. A control is included for competition of the SARS-CoV-2 spike RBD-ACE2 interaction.
SARS-CoV-2 Spike-ACE2 Interaction Inhibitor Screening Assay Kit Reference: 502050-96strip Cayman’s SARS-CoV-2 Spike-ACE2 Interaction Inhibitor Screening Assay Kit provides a robust and easy-to-use platform for identifying novel inhibitors of the SARS-CoV-2 spike and ACE2 interaction. The assay uses a recombinant rabbit Fc-tagged SARS-CoV-2 spike S1 RBD that binds to a plate precoated with a mouse anti-rabbit antibody. A recombinant His-tagged ACE2 protein binds the spike RBD and the complex is detected with an HRP-conjugated anti-His antibody, which is easily quantified by reading the absorbance at 450 nm. A control is included for competition of the SARS-CoV-2 spike RBD-ACE2 interaction.
SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit Reference: 502070-96solid Cayman’s SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit is a competitive assay that can be used for qualitative and/or semi-quantitative measurement of neutralizing antibodies in human plasma and serum. The assay has a range of 7.81-1,000 ng/ml with a midpoint of approximately 107 ng/ml (50% B/B0) and a sensitivity (80% B/B0) of approximately 41 ng/ml.
SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit Reference: 502070-96strip Cayman’s SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit is a competitive assay that can be used for qualitative and/or semi-quantitative measurement of neutralizing antibodies in human plasma and serum. The assay has a range of 7.81-1,000 ng/ml with a midpoint of approximately 107 ng/ml (50% B/B0) and a sensitivity (80% B/B0) of approximately 41 ng/ml.
SARS-CoV-2 Neutralizing Antibody Positive Control Reference: 502073-500 SARS-CoV-2 Neutralizing Antibody Positive Control has been tested and formulated to work exclusively with Cayman’s SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit (Item No. 502070).
SARS-CoV-2 Neutralizing Antibody Standard Reference: 502074-1 SARS-CoV-2 Neutralizing Antibody Standard has been tested and formulated to work exclusively with Cayman’s SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit (Item No. 502070).